Quick Answer
DiaMedica Therapeutics Inc. reported Common Stock Shares Outstanding of 53.74 million shares for the year ending 2025.
- DiaMedica Therapeutics Inc. showed an increase of +25.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from DiaMedica Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: 11.96 million shares | Q2 2019: 12.01 million shares | Q3 2019: 12.01 million shares | Q1 2020: 14.14 million shares | Q2 2020: 14.14 million shares | Q3 2020: 18.74 million shares | Q1 2021: 18.79 million shares | Q2 2021: 18.79 million shares | Q3 2021: 26.44 million shares | Q1 2022: 26.44 million shares | Q2 2022: 26.44 million shares | Q3 2022: 26.44 million shares | Q1 2023: 26.46 million shares | Q2 2023: 37.95 million shares | Q3 2023: 37.95 million shares | Q1 2024: 37.96 million shares | Q2 2024: 42.69 million shares | Q3 2024: 42.77 million shares | Q1 2025: 42.86 million shares | Q2 2025: 43.07 million shares | Q3 2025: 52.08 million shares.
- Over the full 9 years of available data (2017 to 2025), DiaMedica Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 743.6%.
- Historical annual values: Fiscal year 2025: 53.74 million shares | Fiscal year 2024: 42.82 million shares | Fiscal year 2023: 37.96 million shares | Fiscal year 2022: 26.44 million shares | Fiscal year 2021: 26.44 million shares | Fiscal year 2020: 18.75 million shares | Fiscal year 2019: 12.01 million shares | Fiscal year 2018: 11.96 million shares | Fiscal year 2017: 6.37 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: